AF
MRVI icon

Allworth Financial’s Maravai LifeSciences MRVI Stock Holding History

Allworth Financial’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.73K Buy
2,379
+200
+9% +$678 ﹤0.01% 3772
2025
Q4 		$7.08K Buy
2,179
+54
+3% +$182 ﹤0.01% 3501
2025
Q3 		$6.1K Buy
2,125
+1,822
+601% +$4.65K ﹤0.01% 3436
2025
Q2 		$731 Buy
303
+169
+126% +$355 ﹤0.01% 4040
2025
Q1 		$278 Sell
134
-559
-81% -$2.21K ﹤0.01% 3814
2024
Q4 		$3.69K Buy
693
+3
+0.4% +$19 ﹤0.01% 2893
2024
Q3 		$5.73K Sell
690
-61
-8% -$527 ﹤0.01% 2506
2024
Q2 		$6.49K Sell
751
-544
-42% -$4.7K ﹤0.01% 2396
2024
Q1 		$11.2K Buy
1,295
+627
+94% +$4.24K ﹤0.01% 2056
2023
Q4 		$4.38K Buy
668
+278
+71% +$1.8K ﹤0.01% 2325
2023
Q3 		$3.9K Buy
390
+175
+81% +$1.92K ﹤0.01% 2234
2023
Q2 		$2.67K Sell
215
-202
-48% -$2.73K ﹤0.01% 2372
2023
Q1 		$5.84K Buy
417
+329
+374% +$4.72K ﹤0.01% 1980
2022
Q4 		$1.26K Buy
88
+8
+10% +$126 ﹤0.01% 2402
2022
Q3 		$2K Buy
+80
New +$2.01K ﹤0.01% 2180

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Allworth Financial's MRVI Position: Q1 2026 in Review

Allworth Financial increased its Maravai LifeSciences (MRVI) stake by 9.2% in Q1 2026, buying an estimated $678 and bringing the position to 2,379 shares worth $6.73K. The position accounts for ﹤0.01% of the portfolio, ranked #3772.

Allworth Financial first reported a position in MRVI in Q3 2022 and has held it in 15 quarters since. The position peaked at $11.2K in Q1 2024. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Allworth Financial held 2,379 shares of Maravai LifeSciences worth $6.73K as of Q1 2026.
  • Allworth Financial bought 200 Maravai LifeSciences shares in Q1 2026, an estimated $678.
  • Maravai LifeSciences made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #3772 holding.
  • Allworth Financial first reported a position in Maravai LifeSciences in Q3 2022 and has held it in 15 quarters since.
  • Allworth Financial's Maravai LifeSciences position peaked at $11.2K in Q1 2024.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.